Researchers developed a model to study a small molecule's interaction with CD20 protein in lymphoma cells. Compounds from Schisandra chinensis and Lysionotus pauciflorus were found to target CD20, with potential for improving non-Hodgkin lymphoma treatment.
Lysionotin, a natural flavonoid from the plant Maxim, was studied for its pain-relieving properties. It showed potential as an analgesic, indicating possible use as a treatment for pain-related conditions.